• Skip to main content
  • Skip to primary sidebar

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login

News

August 28, 2020 / Venator

SK Capital to Acquire Huntsman’s Remaining Interest in Venator Materials PLC

New York, August 28, 2020 – Funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, today announced that they have entered into a definitive agreement with Huntsman Corporation (NYSE: HUN) to purchase approximately 42.5 million of its shares in Venator Materials PLC for a cash purchase price of approximately $100 million, including a 30-month option for the purchase of the remaining approximately 9.5 million shares at a strike price of $2.15 per share. The transaction is subject to regulatory approvals and is expected to close near year-end.

Barry Siadat, Co-Founder of SK Capital Partners commented, “We have had a long-term focus on the pigments industry and are delighted to have reached an agreement to purchase Huntsman’s remaining interest in Venator. We are also pleased to continue strengthening the relationship we’ve developed with Huntsman Corporation and its President, Chairman and CEO, Peter Huntsman. Huntsman is a clear leader in the global chemical industry, and we feel privileged to acquire their ownership position in Venator, which we view as a world class functional and specialty pigments business with a leadership position in titanium dioxide. We look forward to working with Simon Turner, CEO and President of Venator, and its board to support its growth and improvement.”

About SK Capital

SK Capital is a private investment firm with a disciplined focus on the specialty materials, chemicals and pharmaceuticals sectors. The firm seeks to build strong and growing businesses that create substantial long-term economic value. SK Capital utilizes its industry, operating and investment experience to identify opportunities to transform businesses into higher performing organizations with improved strategic positioning, growth and profitability as well as lower operating risk. SK Capital’s portfolio of businesses generates revenues in excess of $9.0 billion annually, employs more than 10,000 people globally and operates 86 plants in 24 countries. The firm currently has approximately $4.8 billion of assets under management. For more information, please visit www.skcapitalpartners.com.

Primary Sidebar

Latest News

  • SK Capital Announces the Acquisition of Florachem May 2, 2022
  • SK Capital, Tilley-Phoenix Featured in March 7, 2022 Edition of Chemical Week by Frank Esposito March 14, 2022
  • March 8 – International Women’s Day March 7, 2022
image_pdf

To request for a copy of our ESG report, please click here.

© 2022 SK Capital Partners. All Rights Reserved.

Important Disclosures

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
    • Back
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
    • Back
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
    • Back
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login